Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibroblasts | 21 | 2024 | 272 | 6.370 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 11 | 2022 | 21 | 4.170 |
Why?
|
| Cell Lineage | 18 | 2021 | 90 | 2.850 |
Why?
|
| Myocardium | 12 | 2023 | 235 | 2.690 |
Why?
|
| Heart | 10 | 2020 | 180 | 2.380 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 11 | 2021 | 80 | 2.340 |
Why?
|
| Signal Transduction | 17 | 2023 | 1908 | 2.230 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 9 | 2016 | 16 | 1.850 |
Why?
|
| Pericardium | 6 | 2020 | 15 | 1.810 |
Why?
|
| Mice, Transgenic | 20 | 2023 | 617 | 1.660 |
Why?
|
| Fibrosis | 8 | 2023 | 159 | 1.590 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2020 | 286 | 1.400 |
Why?
|
| Integrases | 6 | 2016 | 26 | 1.260 |
Why?
|
| Lung | 5 | 2024 | 446 | 1.250 |
Why?
|
| Mice | 41 | 2024 | 5913 | 1.250 |
Why?
|
| Animals | 51 | 2024 | 15081 | 1.210 |
Why?
|
| Heart Diseases | 2 | 2017 | 104 | 1.050 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 56 | 1.040 |
Why?
|
| Myocardial Infarction | 4 | 2022 | 225 | 1.040 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2012 | 130 | 1.000 |
Why?
|
| Myocytes, Smooth Muscle | 7 | 2019 | 86 | 1.000 |
Why?
|
| Cell Differentiation | 13 | 2024 | 587 | 0.930 |
Why?
|
| Neural Crest | 4 | 2016 | 23 | 0.910 |
Why?
|
| Cell Proliferation | 12 | 2020 | 1198 | 0.880 |
Why?
|
| Homeostasis | 3 | 2021 | 188 | 0.850 |
Why?
|
| Cell Movement | 10 | 2011 | 571 | 0.840 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2015 | 26 | 0.770 |
Why?
|
| Heart Ventricles | 2 | 2019 | 110 | 0.750 |
Why?
|
| Ventricular Remodeling | 2 | 2017 | 57 | 0.730 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2015 | 43 | 0.710 |
Why?
|
| Proteomics | 1 | 2022 | 325 | 0.700 |
Why?
|
| Myocytes, Cardiac | 6 | 2022 | 166 | 0.680 |
Why?
|
| Stem Cells | 5 | 2015 | 141 | 0.680 |
Why?
|
| Phenotype | 10 | 2022 | 689 | 0.640 |
Why?
|
| Endothelial Cells | 3 | 2017 | 308 | 0.610 |
Why?
|
| Embryo, Mammalian | 4 | 2012 | 153 | 0.580 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.560 |
Why?
|
| Recombination, Genetic | 2 | 2016 | 93 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 1609 | 0.480 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1015 | 0.470 |
Why?
|
| Cells, Cultured | 9 | 2021 | 1518 | 0.460 |
Why?
|
| Mice, Knockout | 7 | 2019 | 933 | 0.450 |
Why?
|
| Pregnancy | 7 | 2022 | 1549 | 0.440 |
Why?
|
| Neurofibromin 1 | 1 | 2012 | 2 | 0.420 |
Why?
|
| Kidney | 3 | 2011 | 337 | 0.420 |
Why?
|
| Coronary Vessels | 2 | 2012 | 85 | 0.410 |
Why?
|
| Extracellular Matrix | 3 | 2022 | 115 | 0.410 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2010 | 4 | 0.390 |
Why?
|
| Collagen | 3 | 2022 | 172 | 0.390 |
Why?
|
| Regeneration | 2 | 2021 | 20 | 0.380 |
Why?
|
| Testis | 3 | 2023 | 187 | 0.380 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 664 | 0.370 |
Why?
|
| Humans | 19 | 2024 | 37093 | 0.370 |
Why?
|
| Female | 14 | 2022 | 20969 | 0.330 |
Why?
|
| Yolk Sac | 1 | 2008 | 4 | 0.330 |
Why?
|
| Tamoxifen | 4 | 2022 | 65 | 0.320 |
Why?
|
| Somites | 1 | 2008 | 2 | 0.320 |
Why?
|
| Spinal Dysraphism | 1 | 2008 | 6 | 0.310 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 1371 | 0.310 |
Why?
|
| Heart Failure | 2 | 2022 | 235 | 0.310 |
Why?
|
| Neutrophils | 2 | 2024 | 131 | 0.280 |
Why?
|
| Granulocytes | 2 | 2023 | 29 | 0.280 |
Why?
|
| Male | 12 | 2023 | 20025 | 0.270 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 142 | 0.270 |
Why?
|
| Blood Vessels | 3 | 2012 | 34 | 0.260 |
Why?
|
| Mesoderm | 3 | 2019 | 70 | 0.260 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 12 | 0.240 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 626 | 0.220 |
Why?
|
| Cell Separation | 3 | 2015 | 93 | 0.220 |
Why?
|
| Phenylephrine | 1 | 2022 | 36 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2024 | 517 | 0.200 |
Why?
|
| Angiotensin II | 1 | 2022 | 97 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 149 | 0.190 |
Why?
|
| Zebrafish | 2 | 2020 | 128 | 0.190 |
Why?
|
| Proteome | 1 | 2022 | 144 | 0.190 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 893 | 0.190 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2021 | 62 | 0.190 |
Why?
|
| Embryonic Development | 3 | 2011 | 76 | 0.190 |
Why?
|
| Mutation | 4 | 2015 | 1095 | 0.180 |
Why?
|
| Cell Survival | 2 | 2019 | 864 | 0.180 |
Why?
|
| Enzyme Activation | 3 | 2011 | 444 | 0.180 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 99 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 360 | 0.170 |
Why?
|
| Calcium | 1 | 2022 | 480 | 0.170 |
Why?
|
| Benzimidazoles | 1 | 2019 | 36 | 0.170 |
Why?
|
| Piperidines | 1 | 2019 | 77 | 0.160 |
Why?
|
| Models, Biological | 4 | 2013 | 677 | 0.160 |
Why?
|
| Adipocytes | 1 | 2019 | 58 | 0.160 |
Why?
|
| Time Factors | 3 | 2012 | 1742 | 0.160 |
Why?
|
| Sertoli Cells | 1 | 2018 | 42 | 0.160 |
Why?
|
| Gestational Age | 1 | 2019 | 190 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 119 | 0.160 |
Why?
|
| Isoproterenol | 1 | 2017 | 36 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2017 | 34 | 0.150 |
Why?
|
| Pressure | 1 | 2017 | 43 | 0.150 |
Why?
|
| Skull | 2 | 2010 | 35 | 0.150 |
Why?
|
| Spermatogenesis | 1 | 2018 | 155 | 0.150 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 22 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2017 | 343 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 75 | 0.140 |
Why?
|
| Cell Count | 1 | 2015 | 135 | 0.130 |
Why?
|
| Aorta, Thoracic | 2 | 2007 | 28 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 208 | 0.130 |
Why?
|
| Genotype | 1 | 2017 | 730 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2015 | 399 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 75 | 0.120 |
Why?
|
| Adrenal Cortex | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cell Line | 1 | 2017 | 1354 | 0.120 |
Why?
|
| Steroids | 1 | 2013 | 43 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 59 | 0.110 |
Why?
|
| Fetus | 1 | 2013 | 105 | 0.110 |
Why?
|
| Middle Aged | 2 | 2019 | 10129 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 187 | 0.110 |
Why?
|
| Stromal Cells | 2 | 2013 | 49 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2015 | 249 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 408 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2013 | 50 | 0.110 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2012 | 2 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2024 | 93 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2012 | 8 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 8 | 0.100 |
Why?
|
| Trophoblasts | 1 | 2012 | 24 | 0.100 |
Why?
|
| Adult | 2 | 2019 | 11712 | 0.100 |
Why?
|
| Spleen | 1 | 2012 | 199 | 0.100 |
Why?
|
| Gonads | 1 | 2011 | 20 | 0.100 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 8 | 0.100 |
Why?
|
| Apoptosis | 1 | 2019 | 1398 | 0.100 |
Why?
|
| Placenta | 1 | 2012 | 97 | 0.100 |
Why?
|
| Retina | 2 | 2004 | 280 | 0.100 |
Why?
|
| SOX9 Transcription Factor | 1 | 2011 | 10 | 0.100 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2011 | 12 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 252 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2011 | 136 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2011 | 90 | 0.100 |
Why?
|
| Enteric Nervous System | 1 | 2010 | 1 | 0.100 |
Why?
|
| Species Specificity | 1 | 2011 | 245 | 0.100 |
Why?
|
| Palate | 1 | 2010 | 7 | 0.100 |
Why?
|
| Adherens Junctions | 1 | 2010 | 8 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2013 | 681 | 0.090 |
Why?
|
| Congenital Abnormalities | 1 | 2010 | 21 | 0.090 |
Why?
|
| beta Catenin | 1 | 2010 | 48 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2010 | 54 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2009 | 194 | 0.090 |
Why?
|
| Receptors, LDL | 1 | 2009 | 30 | 0.090 |
Why?
|
| HIV Infections | 1 | 2023 | 2303 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2008 | 28 | 0.080 |
Why?
|
| Adipocytes, White | 1 | 2008 | 3 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 16 | 0.080 |
Why?
|
| Heart Defects, Congenital | 2 | 2013 | 60 | 0.080 |
Why?
|
| Chondrogenesis | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cartilage | 1 | 2008 | 18 | 0.080 |
Why?
|
| Spine | 1 | 2008 | 12 | 0.080 |
Why?
|
| Epithelium | 1 | 2008 | 79 | 0.080 |
Why?
|
| Phosphoserine | 1 | 2008 | 19 | 0.080 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2008 | 19 | 0.080 |
Why?
|
| Tyrosine | 2 | 2009 | 118 | 0.080 |
Why?
|
| ras Proteins | 1 | 2008 | 51 | 0.080 |
Why?
|
| Benzamides | 1 | 2008 | 78 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 136 | 0.070 |
Why?
|
| Piperazines | 1 | 2008 | 111 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2008 | 177 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2008 | 118 | 0.070 |
Why?
|
| Chickens | 1 | 2008 | 133 | 0.070 |
Why?
|
| Oligodendroglia | 1 | 2007 | 24 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 237 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 142 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 269 | 0.070 |
Why?
|
| Alleles | 2 | 2003 | 321 | 0.070 |
Why?
|
| Growth Substances | 1 | 2004 | 14 | 0.060 |
Why?
|
| Lung Injury | 1 | 2024 | 15 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2024 | 27 | 0.060 |
Why?
|
| Aging | 2 | 2023 | 664 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 31 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 618 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2003 | 69 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2003 | 25 | 0.060 |
Why?
|
| Transgenes | 1 | 2003 | 59 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 26 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2024 | 67 | 0.060 |
Why?
|
| Pericytes | 1 | 2003 | 22 | 0.060 |
Why?
|
| Bystander Effect | 1 | 2023 | 11 | 0.060 |
Why?
|
| Point Mutation | 1 | 2003 | 93 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2003 | 143 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2003 | 172 | 0.060 |
Why?
|
| Fetal Heart | 1 | 2003 | 4 | 0.060 |
Why?
|
| Homozygote | 1 | 2003 | 77 | 0.050 |
Why?
|
| raf Kinases | 1 | 2022 | 7 | 0.050 |
Why?
|
| Heterozygote | 1 | 2003 | 93 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 29 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2022 | 32 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2002 | 14 | 0.050 |
Why?
|
| Pregnancy, Animal | 1 | 2002 | 16 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 12 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2002 | 24 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2002 | 23 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2022 | 93 | 0.050 |
Why?
|
| Histones | 1 | 2023 | 190 | 0.050 |
Why?
|
| Leydig Cells | 1 | 2021 | 5 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 859 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 169 | 0.050 |
Why?
|
| Osteoprotegerin | 1 | 2019 | 10 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 369 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 106 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 1492 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2008 | 121 | 0.040 |
Why?
|
| Hyperoxia | 1 | 2016 | 7 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 103 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 129 | 0.030 |
Why?
|
| WT1 Proteins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 47 | 0.030 |
Why?
|
| Premature Birth | 1 | 2016 | 75 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 27 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 767 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 173 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 161 | 0.030 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 562 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 20 | 0.030 |
Why?
|
| Germinal Center | 1 | 2012 | 10 | 0.030 |
Why?
|
| Tail | 1 | 2012 | 6 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2012 | 12 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 11 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 2012 | 7 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2012 | 13 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2012 | 39 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 92 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 185 | 0.020 |
Why?
|
| Germ Layers | 1 | 2008 | 1 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 148 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2008 | 12 | 0.020 |
Why?
|
| Doxycycline | 1 | 2008 | 30 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 167 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2008 | 105 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2008 | 46 | 0.020 |
Why?
|
| Cadherins | 1 | 2008 | 90 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 439 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 53 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 928 | 0.020 |
Why?
|
| Endoderm | 1 | 2002 | 1 | 0.010 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2002 | 3 | 0.010 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2002 | 4 | 0.010 |
Why?
|
| Retinol-Binding Proteins | 1 | 2002 | 6 | 0.010 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2002 | 1 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 37 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 38 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2002 | 28 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 63 | 0.010 |
Why?
|
| Biological Transport | 1 | 2002 | 185 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 147 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 190 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 3483 | 0.010 |
Why?
|